CYC vs NUZ

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CYC

CYCLOPHARM FPO [CYC]

41LOW

NUZ

NEURITHERA FPO [NUZ]

41LOW

Score Breakdown

CYC NUZ
Technical
41
48
Catalyst
51
53
Sentiment
50
50
Fundamental
69
43
Momentum
39
36
Risk Gate
50
50

Key Metrics

CYC Metric NUZ
$61.6MMarket Cap$51.2M
345KAvg Volume (20d)1.1M
N/AShort InterestN/A
$1.29052-Week High$0.185
$0.45052-Week Low$0.055
-6.7%Daily Change-3.0%
$0.490Reference Price$0.065
-49.3%ROE-147.1%
-53.3%Profit Margin-248.4%

Active Signals

CYC Signals

●RSI drifting toward oversold territory — worth watching
●Volume surging at 2.7x normal while price falls — heavy selling pressure
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.5 quarters)
●Low P/S ratio (1.9x)
●Moderate revenue growth (+10%)
●EPS estimates revised upward (+10pts)

NUZ Signals

●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●Moderate P/S ratio (8.6x)
●Strong revenue growth (+290%)
●Near 52-week low (9% of range)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●Deeply negative margins (-248%)

Ask Scout AI to compare CYC and NUZ in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

HIQ vs OSL →MAP vs OSL →NUZ vs OSL →HIQ vs PGC →MAP vs PGC →
CYC Full Analysis → NUZ Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).